Dengue Vaccine
Live attenuated tetravalent dengue vaccine was safe, effective in Thai children
Published in Medical Letter on the CDC and FDA, September 17th, 2006
According to a recent report, "From 1992 to 1997, 140 Thai children 4-15 years of age received an investigational live attenuated tetravalent dengue vaccine (LATDV). These children were contacted three to eight years later in 2001 to assess humoral immunity and investigate whether they were subsequently at higher risk of developing severe dengue."
"One hundred thirteen were successfully contacted and participated in this retrospective cohort study with two age- and address-matched controls per vaccinee," said Pornthep Chanthavanich and colleagues at Mahidol...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Diarrhea Epidemiology
Bacterial diarrhea and antimicrobial resistance in western Kenya were examined - Drug Safety
U.S. FDA warns three pharmacies to stop mass-producing unapproved inhalation drugs - Environmental Health
Mycobacterium enzymes degrade polycyclic aromatic hydrocarbons - Food Safety
Salmonella contamination of eggs is national epidemic in U.S. - Accreditation
Humana Military Healthcare Services receives URAC accreditation - Addiction Medicine
Effectiveness of detoxification programs at detention centers in Taiwan is in question - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
